About Koios Medical
Koios Medical is a private company based in New York, New York. It has reported $11,048,152 raised in five offerings on Form D since February 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Dec 23, 2025 | $0target not set | 0 | — | EquityRule 506(c) | Form D ↗ |
| May 17, 2024 | May 28, 2024amended Jun 24, 2024 | $170,000of $500K target | 4 | $42,500 | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 3, 2023 | Feb 17, 2023 | $7,999,996of $12.0M target | 1 | $7.9M | EquityRule 506(b) | Form D ↗ |
| Nov 16, 2021 | Aug 8, 2022 | $2,598,156of $5.0M target | 25 | $103K | Debt, Convertible NoteRule 506(b) | Form D ↗ |
| Jan 26, 2021 | Feb 3, 2021 | $280,000of $3.0M target | 7 | $40,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, five offerings | $11,048,152 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Koios Medical's Form D filed Dec 23, 2025.
CL
Christine Li
Director
GM
Gregory Moran
Director
RM
Robert Mcclennan
Executive officer and promoter
GA
Graham Anderson
Chief Financial Officer
MG
Mark Glasgold
Director
Earlier filings also listed John Walker (executive officer and promoter, last listed Feb 2023), Christine Shuling (executive officer and promoter, last listed Feb 2023) and William Peterson (director, last listed Aug 2022).